期刊文献+

产AmpC酶鲍曼不动杆菌的耐药表型及基因型分析 被引量:5

Antibiotic-resistant phenotype and genotype of AmpC β-lactamase in acinetobacter baumannii
暂未订购
导出
摘要 目的通过对鲍曼不动杆菌产AmpCβ-内酰胺酶的耐药表型及基因型分析,研究其耐药特征和流行趋势。方法收集2010年1月至10月两所综合性医院临床分离的多重耐药鲍曼不动杆菌63株,采用琼脂扩散法进行药物敏感试验,采用聚合酶链反应检测AmpC酶。结果 63株鲍曼不动杆菌耐头孢西丁61株(96.8%),而且对临床其他常用抗生素的耐药率也非常高,均在90%以上(除亚胺培南,美罗培南,米诺环素,阿米卡星,头孢哌酮/舒巴坦,替卡西林/棒酸),表现为多重耐药,其中对米诺环素的敏感率最高为56%,头孢哌酮/舒巴坦位列第二为41.3%。所测63株鲍曼不动杆菌中AmpC酶阳性率为67%。结论鲍曼不动杆菌多重耐药有蔓延趋势,出现1株对临床现有抗生素全部耐药的菌株。AmpC酶在鲍曼不动杆菌的耐药机制中起重要作用,其携带率为67%。米诺环素和头孢哌酮/舒巴坦是目前本地区最为有效的抗菌药物。 Objective To study the resistance characteristics and the tendency of AmpC β-lactamase in acinetobacter baumannii by analyzing their resistant phenotype and genotype in Shanxi province.Methods Totally 63 strains of multidrug resistant acinetobacter baumannii were collected by clinical dissociation from two comprehensive hospitals of Shanxi province from January to October of 2010.Drug sensitivity test was performed by agar diffusion method.Polymerase chain reaction(PCR) was used to detect AmpC enzyme.Results Sixty-one strains out of the 63 were resistant to cefoxitin,with a resistant rate of 97%,and the resistant rates to other commonly used antibiotics were also rather high,all above 90% except for imipenem,meropenem,minocycline,amikacin,cefoperazone /sulbactam,ticarcillin /clavulanic acid.Multiple drug resistance was noted,and the sensitivity rate to minocycline was the top rate,at 56%,that to cefoperazone /sulbactam ranked the second,at 41%.AmpC enzyme positive rate was 67% in all the 63 strains of acinetobacter baumannii.Conclusion The situation of acinetobater baumannii resistance is very serious in Shanxi province,and multiple drug resistance is spreading.A strain resisting all current antibiotics is noted.AmpC enzyme plays an important role in acinetobater baumanii drug-resistant mechanism,the carrying rate of which is 67%.Minocycline and cefoperazone /sulbactam are presently the most effective antibiotics in Shanxi.
出处 《中国药物与临床》 CAS 2011年第7期772-774,共3页 Chinese Remedies & Clinics
基金 山西省归国留学人员课基金(2010-14-94)
关键词 鲍曼不动杆菌 AMPC酶 耐药性 Acinetobacter baumannii AmpC enzyme Antibiotic resistance
  • 相关文献

参考文献9

  • 1Bou G,Cervero G,Dominguez MA,et al. Characterization of a nosocomial outbreak caused by a multiresistant acinetobaeter baumannii strain with a carbapenem-hydrolyzing enzyme:high- level carbapenem resistance in A.baumannii is not due solely io the presence of β-1aetamases. J Clin Mierobiol,2000,38 (9): 3299-3305.
  • 2黄金莲,应雄江,胡苏球.132株鲍氏不动杆菌耐药性监测与分析[J].中国抗生素杂志,2004,29(2):96-98. 被引量:14
  • 3Scott P,Deye G,Srinivasan A,et al. An outbreak of multidrug- resistant acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military op- erations in lraq. Clin Infect Dis,2007,44( 12): 1577-1584.
  • 4Patricia A,Bradford PA. Extended-spectum β-1actamases in the 21st century: characterization epidemiology and detection of this importance theat. Clin Microbiol Rev, 2001,14 (4) : 933-943.
  • 5李艳,李玉.AmpC酶的研究进展[J].医学综述,2002,8(12):683-685. 被引量:6
  • 6张永龙,李家泰,赵鸣武.AmpC酶的研究进展[J].中国临床药理学杂志,1999,15(5):381-388. 被引量:10
  • 7刘韫秀,苏青,张朋.鲍曼不动杆菌AmpC酶的检测[J].中国微生态学杂志,2010,22(7):671-672. 被引量:2
  • 8Vila J,Ruiz J,Goni P,et al. Quirelone-resistance mutations in the topoisomerase IV par C gene of acinetobacter haumanaii. J Antimicrob Chemnther, 1997,39(6) : 757-762.
  • 9Vila J,Ruiz J,Goni P,et al. ?dutation in the gyrA gene of quinolone- resistant clinical isolates of acinetobaeter baumannii. Antimiemb Agents Chemother, 1995,39(5 ) : 1201-1203.

二级参考文献35

  • 1王辉,刘颖梅,陈民钧,孙宏莉,谢秀丽,徐英春.鲍曼不动杆菌对碳青霉烯类耐药机制的研究[J].中国医学科学院学报,2003,25(5):567-572. 被引量:44
  • 2王辉,孙宏莉,宁永忠,杨启文,陈民钧,朱元珏,徐英春,谢秀丽.不动杆菌属多重耐药及泛耐药的分子机制研究[J].中华医学杂志,2006,86(1):17-22. 被引量:183
  • 3KARLOWSKY A, JONES M E, DRAGHI I X, et al. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001 [ J ]. Antimicrob Agents Chemother,2003, 47(5) :1681-1688.
  • 4WANG H,CHEN M, NI Y, et al. Antimicrobial resistance analysis among nosocomial gram-negative bacilli from 10 teaching hospitals in China[J]. Chin J Lab Med,2005,12(28) :1295-1303.
  • 5MARCHAND I M DAMIER-PIOLLE L,COURVALIN P,et al. Expression of RND-type effiux pump AdeABC in Acinetobacter baumanaii is regulated by the adeRS two-component system[ J]. Antimicrob Agents Chemother,2004,48 ( 9 ) :3298-3304.
  • 6THEN R L. Ability of new lactam antibiotics to induce 13-lactamases production in Enterohacter cloacae [ J ]. Eur J Clin Mcrobiol, 1987,6 (2) :451-455.
  • 7LOPE Z, YESTE M, XERCAVINS M, et al. Fluortxtuir-lone and aminoglycoside resistance in chromosomal overproducing gram-negative bacilli strains with inducible beta-lactamase[ J]. J Enferm Infeet Microbiol Clin,1996,14(4) :211-214.
  • 8SANDELS C C ,SANDERS W E. Type I beta-lactamase of gram-negative bactena :interactions with betarn amtibiotlcs [ J ]. J lnfet Dis, 1986, 154(6) :792-800.
  • 9COUDRON P E,MOLAND E S,THOF K S. Turrence and detection of AmpC beta-laetamases among Escherichia coli, 10, ebsiella pneumoniae, and proteus mirabilis isolates at a veterans medical center [ J]. J Clio Microbiol,2000,38 ( 5 ) : 1791-1796.
  • 10POIREL L, MENUTEAU O, AGOLI N, et al. Outbreak of extendedspectrum B-Lactamas VEB-1 producing isolates of Acinetobacter baumannii in a french hospital [ J ]. J Clin Microbiol, 2003, 39 ( 8 ) : 3542 -3547.

共引文献27

同被引文献73

  • 1王艳丽,黄茂,梅亚宁,殷凯生.鲍曼不动杆菌对喹诺酮类药物的耐药机制研究[J].中国感染与化疗杂志,2008,8(4):266-270. 被引量:24
  • 2曹春鸾.多重耐药鲍曼不动杆菌β-内酰胺酶基因型研究[J].实用医技杂志,2006,13(2):173-176. 被引量:6
  • 3郭萍,王辉,陈端,杨启文,徐英春,陈民钧.OXA-51样D类碳青霉烯酶在鲍曼不动杆菌中广泛分布[J].中华检验医学杂志,2007,30(5):505-509. 被引量:19
  • 4Brown S,Young HK,Amyes SGB.Characterization of OXA-51,a novelclass D carbapenemase found in genetically unrelated clinical strains ofAcinetobacter baumannii from Argentina[J].Clin Microbiol Infect,2005,11:15-23.
  • 5D'Arezzo S,Capone A,Petrosillo N,et al.Epidemic multidrug-resis-tant Acinetobacter baumannii related to European clonal types I and IIin Rome(Italy)[J].Clin Microbiol Infect,2009,15(4):347-357.
  • 6Héritier C,Poirel L,Fournier PE,et al.Characterization of the naturallyoccurring oxacillinase of Acinetobacter baumannii[J].Antimicrob A-gentsChemother,2005,49:4174-4179.
  • 7Poirel L,Mansour W,Bouallegue O,et al.Carbapenem-resistant acine-tobacter baumannii isolates from Tunisia producing the OXA-58-likecarbapenem-hydrolyzing oxacillinase OXA-97[J].Antimicrobial A-gents Chemother,2008,52:1613-1617.
  • 8Higgins PG,Lehmann M,Seifert H.Inclusion of OXA-143primers in amultiplex polymerase chain reaction(PCR)for genes encoding preva-lent OXA carbapenemases in Acinetobacter spp[J].Int J AntimicrobAgents,2010,305:35.
  • 9Kim CK,Lee Y,Lee H,et al.Prevalence and diversity of carbapene-mases among imipenem-nonsusceptible Acinetobacter isolates in Kore-a:emergence of a novel OXA-182[J].Diagn Microbiol Infect Dis,2010,68(4):432-438.
  • 10Shakil S,Khan R,Zarrilli R,et al.Aminoglycosides versus bacteria-adescription of the action,resistancemechanism,and nosocomial battle-ground[J].J Biomed Sci,2008,15(1):5-14.

引证文献5

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部